10. New Hope To End Obesity
What It Can Do: Aid In Weight Loss
Discovered By: Novo Nordisk
Est. Cost: $1,300/Month*
Over the years, there have been countless methods that people have tried to help combat their chronic weight issues, but, as of yet, few have been as effective as Novo Nordisk’s, FDA approved, Wegovy, or Semaglutide, as it’s known to pharmacists. Interestingly enough, in smaller doses, Wegovy was originally intended (and still used), to help adults who have been diagnosed with Type 2 diabetes.
By no means is this new medication by Novo Nordisk a cure-all for obese individuals, however, when used alongside a balanced diet and light exercise, has been shown to reduce a patient’s body-weight by an average of 14.9% over a 15+ month trial – which was more than 12% more weight lost than those in the placebo group.